|
Product Description
|
Recall Class
|
FDA Recall Posting Date
|
Recalling Firm
|
Z-0821-2023 - ETEST CLINICAL CEFTRIAXONE TX 32 US S30, CATALOG 412302
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0863-2023 - ETEST CLINICAL COLISTIN CO 256 US B100, CATALOG 537348
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0851-2023 - ETEST CLINICAL ERAVACYCLINE ERV US S30, CATALOG 421553
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0822-2023 - ETEST CLINICAL ERTAPENEM ETP 32 US S30, CATALOG 412331
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0823-2023 - ETEST CLINICAL ERYTHROMYCIN EM 256 US S30, CATALOG 412333
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0859-2023 - ETEST CLINICAL ETEST MEROPENEM MP M100 US, CATALOG 423786
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0852-2023 - ETEST CLINICAL ETEST MEROPENEM/VABORBACTAM MEV US S30, CATALOG 421560
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0860-2023 - ETEST CLINICAL ETEST VANCOMYCIN VA M100 US, CATALOG 423788
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0824-2023 - ETEST CLINICAL FLUCONAZOLE FL 256 US S30, CATALOG 412333
|
2
|
01/04/2023
|
Biomerieux Inc
|
Z-0825-2023 - ETEST CLINICAL IMIPENEM IP 32 US S30, CATALOG 412373
|
2
|
01/04/2023
|
Biomerieux Inc
|